The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
60
about 4.9 years
19–75
1 site in AL
About this study
This trial is testing whether a treatment called MitoQ can help reduce racial disparities in blood vessel function and nervous system regulation of blood pressure. The goal is to understand if mitochondrial reactive oxygen species influence blood vessel function and nervous system regulation of blood pressure differently in Black individuals compared to White individuals, potentially explaining why Black people are at higher risk for cardiovascular disease.
Based on ClinicalTrials.gov records.
What participants do
- 1.MitoQ
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
dietary supplement
Primary: Changes in blood pressure reactivity
Secondary: Cardiorespiratory fitness, Physical activity
Renal